Contribution of 3D printing for the surgical management of jaws cysts and benign tumors: A systematic review of the literature.

3D printing Benign jaw tumor Guided surgery Jaw cyst Virtual surgical planning

Journal

Journal of stomatology, oral and maxillofacial surgery
ISSN: 2468-7855
Titre abrégé: J Stomatol Oral Maxillofac Surg
Pays: France
ID NLM: 101701089

Informations de publication

Date de publication:
09 2023
Historique:
received: 07 03 2023
accepted: 08 03 2023
medline: 28 8 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

Three-dimensional (3D) printing is now a widely recognized surgical tool in oral and maxillofacial surgery. However, little is known about its benefits for the surgical management of benign maxillary and mandibular tumors and cysts. The objective of this systematic review was to assess the contribution of 3D printing in the management of benign jaw lesions. A systematic review, registered in PROSPERO, was conducted using PubMed and Scopus databases, up to December 2022, by following PRISMA guidelines. Studies reporting 3D printing applications for the surgical management of benign jaw lesions were considered. This review included thirteen studies involving 74 patients. The principal use of 3D printing was to produce anatomical models, intraoperative surgical guides, or both, allowing for the successful removal of maxillary and mandibular lesions. The greatest reported benefits of printed models were the visualization of the lesion and its anatomical relationships to anticipate intraoperative risks. Surgical guides were designed as drilling locating guides or osteotomy cutting guides and contributed to decreasing operating time and improving the accuracy of the surgery. Using 3D printing technologies to manage benign jaw lesions results in less invasive procedures by facilitating precise osteotomies, reducing operating times, and complications. More studies with higher levels of evidence are needed to confirm our results.

Sections du résumé

BACKGROUND
Three-dimensional (3D) printing is now a widely recognized surgical tool in oral and maxillofacial surgery. However, little is known about its benefits for the surgical management of benign maxillary and mandibular tumors and cysts.
PURPOSE
The objective of this systematic review was to assess the contribution of 3D printing in the management of benign jaw lesions.
METHODS
A systematic review, registered in PROSPERO, was conducted using PubMed and Scopus databases, up to December 2022, by following PRISMA guidelines. Studies reporting 3D printing applications for the surgical management of benign jaw lesions were considered.
RESULTS
This review included thirteen studies involving 74 patients. The principal use of 3D printing was to produce anatomical models, intraoperative surgical guides, or both, allowing for the successful removal of maxillary and mandibular lesions. The greatest reported benefits of printed models were the visualization of the lesion and its anatomical relationships to anticipate intraoperative risks. Surgical guides were designed as drilling locating guides or osteotomy cutting guides and contributed to decreasing operating time and improving the accuracy of the surgery.
CONCLUSION
Using 3D printing technologies to manage benign jaw lesions results in less invasive procedures by facilitating precise osteotomies, reducing operating times, and complications. More studies with higher levels of evidence are needed to confirm our results.

Identifiants

pubmed: 36914002
pii: S2468-7855(23)00056-3
doi: 10.1016/j.jormas.2023.101433
pii:
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101433

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no conflicts of interest

Auteurs

Steven Gernandt (S)

Division of Oral and Maxillofacial Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.

Olivia Tomasella (O)

UFR des Sciences Odontologiques, Univ. Bordeaux, 33000 Bordeaux, France.

Paolo Scolozzi (P)

Division of Oral and Maxillofacial Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland. Electronic address: paolo.scolozzi@hcuge.ch.

Mathilde Fenelon (M)

Division of Oral and Maxillofacial Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland; UFR des Sciences Odontologiques, Univ. Bordeaux, 33000 Bordeaux, France; Service de chirurgie orale, CHU de Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH